Cargando…
TMSB4X: A novel prognostic marker for non-small cell lung cancer
Non-small cell lung cancer (NSCLC), as the main type of lung cancer, has a long history of high incidence and mortality. Despite the continuous updates to the American Joint Committee on Cancer (AJCC) staging system, which adapt to evolving treatment modalities and diagnostic advancements, it is evi...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663839/ https://www.ncbi.nlm.nih.gov/pubmed/38027718 http://dx.doi.org/10.1016/j.heliyon.2023.e21505 |